A novel neutralizing epitope of human cytomegalovirus glycoprotein M screened by phage display

Progress in Biochemistry and Biophysics

Volumn 36, Issue 2, 2009, Pages 220-227

  Wang, Ben Xu ^b   Liu, Yu ^a   Liu, Zhan ^c   Gao, Ya Ping ^a   Wang, Fang ^a   Pan, He Ping ^a   Yang, Guang ^a   Xu, Hua ^a   Shen, Bei Fen ^a   Liu, Chuan ^a   Shao, Ning Sheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Center of Disease Control and Prevention   (China)

^c Huairou Maternal and Child Health Hospital   (China)

Author keywords

Glycoprotein M; Human cytomegalovirus; Neutralizing epitope

Indexed keywords

HUMAN HERPESVIRUS 5; MUS;

EID: 67649529367     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00391     Document Type: Article

References (19)

1. Britt W J, Alford C A. Cytomegalovirus. In: Field B, Knipe N, Howley DMPM, eds. Virology. Philadelphia: Lippincott/Raven, 1996. 2493-523
2. Perry C M, Faulds D, Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs, 1996,52(5): 754-772
3. Chou S, Marousek G, Guentzel S, et al. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J Infect Dis, 1997,176(3):786-789
4. 4BrittWJ,AugerD.Synthesisandprocessingoftheenvelopegp55- l16complexofhumancytomegalovirus.JVirol,1986,58(1):185~191(Pubitemid16021975)
5. Speckner A, Kropff B, Knor S, et al. The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond. J Gen Virol, 2000,81(Pt11): 2659-2663
6. Gicklhorn D, Eickmann M, Meyer G, et al. Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion. J Gen Virol, 2003, 84 (Pt7): 1859-1862
7. Chou S W, Dennison IC M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization related epitopes. J Infect Dis, 1991,163(6): 1229-1234
8. Meyer-Konig U, Vogelberg C, Bongarts A, et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol, 1998,55(1): 75-81
9. Vamum S M, Streblow D N, Monroe M E, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol, 2004,78(20): 10960-10966
10. 10LehnerR,MeyerH,MachM. Identificationandcharacterizationofahumancy tomegalovirusgenecodingforamembrane proteinthatisconservedamonghumanherpesviruses.JVirol,1989,63(9): 3792-3800(Pubitemid19205451)
11. Britt W J, Auger D. Identification of a 65000 dalton virion envelope protein of human cytogemalo virus. Virus Res, 1985,4(1): 31-36 (Pubitemid 16210898)
12. Shen S, Wang Sh, Britt W J, et al. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates. Vaccine, 2007,25(17): 3319-3327
13. Shimamura M, Mach M, Britt W J. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response. J Virol, 2006,80(9): 4591-4600
14. Casey J L, Coley A M, Street G, et al. Peptide mimotope selected from a random peptide library for diagnosis of Epstein-Barr virus infection. J Clin Microbiol, 2006,44(3): 764-771
15. Andreoni M, Faircloth M, Vugler L, et al. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods, 1989,23(2): 157-167
16. Ohlin M, Undqvist V A, Mach M, et al. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol, 1993,67(2): 703-710
17. Simpson J A, Chow J C, Baker J, et al. Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites. J Virol, 1993,67(1): 489-496
18. Mach M, Kropff B, Kal Monte P, et al- Complex formation by human cytomegalovirus glycoprotein M (gpUL100) and N (gpUL73). J Virol, 2000,74(24): 11881-11892
19. Mach M, Kropff B, Kryzaniak M, et al. Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects. J Virol, 2005,79(4): 2160-2170